Jasper Therapeutics
JSPR
JSPR
64 hedge funds and large institutions have $69.5M invested in Jasper Therapeutics in 2025 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 67 → 64 (-3)
15% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 20
23% less call options, than puts
Call options by funds: $232K | Put options by funds: $302K
Holders
64
Holding in Top 10
4
Calls
$232K
Puts
$302K
Top Buyers
| 1 | +$959K | |
| 2 | +$654K | |
| 3 | +$587K | |
| 4 |
Morgan Stanley
New York
|
+$570K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$425K |
Top Sellers
| 1 | -$2.77M | |
| 2 | -$902K | |
| 3 | -$653K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$583K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$529K |